Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 1 Jan 2015

Kirnichnaya K A, Sosin D N, Ivanov M V, Mikhaylov V A, Ivashchenko D V, Ershov E E, Taraskina A E, Nasyrova R F, Krupitsky E M

Abstract excerpt

"Typical" antipsychotics remain the wide-prescribed drugs in modern psychiatry. But these drugs are associated with development of extrapyramidal symptoms (EPS). Preventive methods of EPS are actively developed and they concentrate on personalized approach. The method of taking into account genetic characteristics of patient for prescribing of treatment was proven as effective in cardiology, oncology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Basal Ganglia Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BDNF gene

Share to Genetic Markers

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Pharmacogenetics

Share to Risk Assessment

Source

Identifiers

PMID: 26322366
DOI: 10.17116/jnevro201511541113-125

Genes

BDNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].PMID 26322366Read ↗

The Role of Pharmacogenetic Testing in Optimizing Antipsychotic TherapySemantic proximity Read ↗

Personalized antipsychotic treatment: the adverse effects perspectives.Semantic proximity Read ↗

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia.Semantic proximity Read ↗

Genetics of Common Antipsychotic-Induced Adverse EffectsSemantic proximity Read ↗

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Semantic proximity Read ↗

[Clinical significance of the pharmacogenetics in psychiatric and neurological syndromes].Semantic proximity Read ↗

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Semantic proximity Read ↗

Pharmacogenetic Studies of Psychotropic Drug-Induced Adverse Effects.Semantic proximity Read ↗

Genetic Predictors of Antipsychotic Efflux Impairment via Blood-Brain Barrier: Role of Transport ProteinsSemantic proximity Read ↗

Pharmacogenetics of AntipsychoticsSemantic proximity Read ↗

Pharmacogenetic and Pharmacogenomic Research in Psychiatry: Current Advances and Clinical Applications.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced side effectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.